Psoriasis is an incurable chronic skin condition known to affect more than 8 million people in China. China’s psoriasis market has grown...
Non-small-cell lung cancer (NSCLC)—the leading cause of cancer-related deaths in China—has a highly dynamic drug development pipeline, with...
COMING SOON Breast cancer is one of the most frequently diagnosed cancers among Chinese women. A high incidence and a prolonged treatment duration...
Acute myeloid leukemia (AML) is the most common form of adult leukemia but has the lowest five-year overall survival rates of all blood cancers...
Hepatitis B virus (HBV) infection is a major public health burden in China, and chronically infected HBV patients are at a high risk of developing...
MARKET OUTLOOK China has the highest incidence of gastric cancer (gastric and gastroesophageal junction adenocarcinoma) in the world, and...
MARKET OUTLOOK Colorectal cancer, a major public health concern in China, is expected to become the second most common form of cancer there by...
MARKET OUTLOOK Rheumatoid arthritis (RA) is a chronic and progressive autoimmune disease that prima...
MARKET OUTLOOK NASH is a chronic disease that causes extensive and potentially fatal liver fibrosis; it is a leading c...
Bladder cancer is one of the most commonly diagnosed cancers and a substantial cause of cancer-related deaths in China. The bladder cancer market is...
MARKET OUTLOOK Multiple myeloma is an incurable hematological malignancy with a 100% mortality rate that affects a sizeable Chinese population...
MARKET OUTLOOK Non-small cell lung cancer (NSCLC) is one of the most commonly diagnosed cancers and the leading cause of cancer-related deaths in...
MARKET OUTLOOK The hepatocellular carcinoma (HCC) market in China is poised to experience a sudden explosion in market growth. Availability of...
MARKET OUTLOOK Multiple Sclerosis (MS), a chronic immune-mediated disease of the nervous system, is classified as a rare disease in China because...
Type 2 diabetes (T2D) is one of the biggest health challenges in China, where the prevalence of disease is globally the highest. Traditional...
DRG Epidemiology's coverage of gastric cancer comprises epidemiological estimates of key patient populations across 45 countries worldwide. We...
DRG Epidemiology's coverage of esophageal cancer comprises epidemiological estimates of key patient populations across 45 countries worldwide...
DRG Epidemiology’s coverage of cystic fibrosis (CF) comprises epidemiological estimates of key patient pop...
Get content updates to your inbox
Subscribe